UA7412A1 - Method for treating psoriasis - Google Patents

Method for treating psoriasis

Info

Publication number
UA7412A1
UA7412A1 UA4351585A UA4351585A UA7412A1 UA 7412 A1 UA7412 A1 UA 7412A1 UA 4351585 A UA4351585 A UA 4351585A UA 4351585 A UA4351585 A UA 4351585A UA 7412 A1 UA7412 A1 UA 7412A1
Authority
UA
Ukraine
Prior art keywords
day
treating psoriasis
seances
cholecalciferol
total
Prior art date
Application number
UA4351585A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Павло Миколайович Hедобій
Володимир Григорович Коляденко
Владимир Григорьевич Коляденко
Original Assignee
Український Державний Медичний Університет Ім. Академіка О.О. Богомольця
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Український Державний Медичний Університет Ім. Академіка О.О. Богомольця filed Critical Український Державний Медичний Університет Ім. Академіка О.О. Богомольця
Priority to UA4351585A priority Critical patent/UA7412A1/en
Publication of UA7412A1 publication Critical patent/UA7412A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The method for treating psoriasis comprises the intake of the medicines, their application onto the lesions, and the use of physiotherapeutic factors. With the aim of increasing the remissions, 1% solution of Novocain is injected to each acupuncture point in the volume up to 2.0 mL. The procedures are performed with 5-6-day intervals, 3-4 seances in total. In 2-3 hours, the oil solution of cholecalciferol is applied to the lesions followed by the exposure to the ultrasound for 5-7 minutes, with the power density of 0.1-0.4 W/cm2, 8-10 seances in total, every other day. Cholecalciferol is taken for 20 days daily at a dose of 25 000 IU thrice a day with the meals.
UA4351585A 1987-12-28 1987-12-28 Method for treating psoriasis UA7412A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA4351585A UA7412A1 (en) 1987-12-28 1987-12-28 Method for treating psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA4351585A UA7412A1 (en) 1987-12-28 1987-12-28 Method for treating psoriasis

Publications (1)

Publication Number Publication Date
UA7412A1 true UA7412A1 (en) 1995-09-29

Family

ID=74556424

Family Applications (1)

Application Number Title Priority Date Filing Date
UA4351585A UA7412A1 (en) 1987-12-28 1987-12-28 Method for treating psoriasis

Country Status (1)

Country Link
UA (1) UA7412A1 (en)

Similar Documents

Publication Publication Date Title
GEP20002146B (en) Therapeutic Peptide Derivatives
ATE78169T1 (en) TREATMENT OF DIABETES THROUGH COMBINED INSULIN FORMS.
ATE135231T1 (en) USE OF ''CARTILAGE-INDUCING FACTOR'' (CIF) TO TREAT HEMATO- OR LYMPHOPOIETIC DISEASES
DE69617469D1 (en) TREATMENT OF MULTIPLE Sclerosis
DE3583849D1 (en) USE OF INTERFERON GAMMA (IFN-GAMMA) CONTAINERS FOR THE SYSTEMIC TREATMENT OF VARIOUS DISEASES OF HUMAN IN LOW DOSAGE.
NO923859L (en) DRUG
DE59407336D1 (en) Use of cineol or menthol to treat asthma
EP0137356A3 (en) Covalently bound heparin - antithrombin-iii complex, method for its preparation and its use for treating thromboembolism
DE59409394D1 (en) THERAPEUTIC SYSTEM FOR TREATING PSORIASIS
UA7412A1 (en) Method for treating psoriasis
JPS6483020A (en) Medicinal composition for preventing or treating aids
EP0338679A3 (en) Tumour necrosis factor in the treatment of bladder cancer
KR890000108A (en) Pharmaceutical composition for the treatment of tumor
PL331104A1 (en) Therapeutic application of bam (cd40l) technology in treating diseases related to smooth muscles
ATE207359T1 (en) COMBINATION THERAPY FOR ADVANCED CANCER WITH TEMOZOLOMIDE AND CISPLATIN
DE69600367D1 (en) Use of sulfasalazine and / or its active metabolites in the manufacture of a medicament for the treatment of venous insufficiency and venous ulcers
PH23658A (en) Improved method of treating tumors with autologous lymphokine activated killer,interleukin-2 and an ornithine decarboxylase inhibitor
Lloret et al. Treatment of renal colic with dipyrone. A double-blind comparison trial with hyoscine alone or combined with dipyrone
AU7373196A (en) Combination of temozolomide and alpha-ifn for the treatment of advanced cancer
SE9002731D0 (en) PRODUCT COMPRISING GROWTH FACTOR
PT80214B (en) Process for the preparation of a pharmaceutical composition containing 9alpha,11beta-dichloro 16alpha-methyl 21-oxycarbonyldicyclohexyl-methyloxi-pregne-1,4-diene 3,20-dione as active agent and an inert product as excipient appropriate to permit r said composition to be used in the rectum or colon
AU8159882A (en) Analgesic potentiation of zomepirac with butorphanol
ATE69551T1 (en) COMPOSITION FOR TREATMENT OF MALIGNANT TUMORS, ESPECIALLY IN ANIMALS.
JPS56108712A (en) Lecithin cholesterol acyl transferase activator
MX9603833A (en) Improved cancer treatment with temozolomide.